CIK 0001130598 · Non-accelerated filer<br>Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-08 | Dukes Iain D. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +231,336 | 231,336 | ||
| 2026-03-08 | Leaman John Harold Director | Grant or award · Stock Option (right to buy) | +33,435 | 33,435 | ||
| 2026-03-08 | CAUTREELS WERNER Director | Grant or award · Stock Option (right to buy) | +31,258 | 31,258 | ||
| 2026-03-08 | STOVER JACK E Director | Grant or award · Stock Option (right to buy) | +33,435 | 33,435 | ||
| 2025-12-12 | Parker Charles Nolan Chief Financial Officer | Grant or award | +15,393 | 15,393 | ||
| 2025-12-12 | Parker Charles Nolan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +61,571 | 61,571 | ||
| 2025-12-12 | Redfield Robert Chief Medical Officer | Grant or award | +16,419 | 113,919 | ||
| 2025-12-12 | Redfield Robert Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +65,676 | 65,676 | ||
| 2025-12-12 | Pauza Charles David Chief Science Officer Virology | Grant or award | +18,471 | 115,971 | ||
| 2025-12-12 | Pauza Charles David Chief Science Officer Virology | Grant or award · Stock Option (right to purchase) | +73,886 | 73,886 | ||
| 2025-12-12 | Savchuk Nikolay Chief Operating Officer | Grant or award | +16,419 | 150,606 | ||
| 2025-12-12 | Savchuk Nikolay Chief Operating Officer | Grant or award · Stock Option (right to purchase) | +65,676 | 65,676 | ||
| 2025-12-12 | Clarke Trafford Director | Grant or award | +6,157 | 6,157 | ||
| 2025-12-12 | Clarke Trafford Director | Grant or award · Stock Option (right to purchase) | +24,629 | 24,629 | ||
| 2025-12-12 | Shoemaker Mary Teresa Director | Grant or award | +6,157 | 6,292 | ||
| 2025-12-12 | Shoemaker Mary Teresa Director | Grant or award · Stock Option (right to purchase) | +24,629 | 24,629 | ||
| 2025-12-12 | Dukes Iain D. Chief Executive Officer | Grant or award | +36,943 | 171,130 | ||
| 2025-12-12 | Dukes Iain D. Chief Executive Officer | Grant or award · Stock Option (right to purchase) | +147,771 | 147,771 | ||
| 2025-12-12 | Leaman John Harold Director | Grant or award | +4,058 | 4,058 | ||
| 2025-12-12 | Leaman John Harold Director | Grant or award · Stock Option (right to purchase) | +16,234 | 16,234 |
Page 2 of 9 · 170 trades